Because of its importance in macronutrient metabolism, PPAR‐γ is a promising target for synthetic insulin sensitizers such as thiazolidinediones in the treatment of type 2 diabetes mellitus (Feige et al., 2006). The gene discussed is PPARG; the disease is diabetes mellitus.